A new study has found that drugs used by millions of diabetes patients can help reduce asthma attacks by 70 percent.
In the study published in JAMA Internal Medicine, researchers examined nearly 13,000 diabetes and asthma patients, which revealed that a drug called metformin reduced asthma attacks in patients by 30 percent, while the GLP-1 drug reduced it by 40 percent.
The authors said that the effects of metformin and GLP-1 could work directly to relax the airways in asthma, in addition to controlling blood sugar or losing weight.
The head of the research team, Chloe Bloom, said that the results suggest that antidiabetic drugs have the potential to be an alternative treatment for asthma.